
Vincent Ma, MD, discusses the next steps in proving the value of circulating tumor DNA in predicting outcomes of advanced melanoma treatment.
Vincent Ma, MD, is an assistant professor at the University of Wisconsin School of Medicine and Public Health who specializes in treating melanoma and advanced cutaneous malignancies.

Vincent Ma, MD, discusses the next steps in proving the value of circulating tumor DNA in predicting outcomes of advanced melanoma treatment.

In an interview, Vincent Ma, MD, explores the clinical utility of circulating tumor DNA dynamics to assess early outcomes in patients with melanoma.

Vincent Ma, MD, discusses a study evaluating circulating tumor DNA early in treatment of metastatic melanoma using immune checkpoint inhibitors.

In an interview, Vincent Ma, MD, discussed how ctDNA levels after the first cycle of immune checkpoint inhibitor in melanoma could shed light on clinical outcomes.